Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.40 |
| ▸ | ADH1C | P00326 | 1/20 | 0.40 |
| ▸ | ADH1A | P07327 | 1/20 | 0.40 |
| ▸ | ADH4 | P08319 | 1/20 | 0.40 |
| ▸ | ADH7 | P40394 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4271879 | 1.00 | ACE2 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL671349 | 1.00 | ACE2 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL4274565 | 1.00 | ACE2 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27223056 | 1.00 | ACE2 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL1873151 | 0.97 | OPRM1 (0.48) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL1645053 | 0.95 | ACE2 (0.45) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27223874 | 0.95 | ACE2 (0.45) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27470379 | 0.95 | ACE2 (0.45) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27345411 | 0.92 | OPRM1 (0.44) | ACE2OPRM1LMNASPHK1TSHR | |
| SCHEMBL27753327 | 0.92 | LMNA (0.55) | ACE2OPRM1LMNASPHK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263612-A1 | Hydrodeoxygenation of Phenolic Lipids and Renewable Hydrocarbon Fuels Produced Therefrom | RENEWABLE ENERGY GROUP, INC. (US) | 2025-08-21 | — | — | US | disclosed |
| US-12275906-B2 | Hydrodeoxygenation of phenolic lipids and renewable hydrocarbon fuels produced therefrom | RENEWABLE ENERGY GROUP, INC. (US) | 2025-04-15 | — | — | US | disclosed |
| US-20240124791-A1 | Hydrodeoxygenation of Phenolic Lipids and Renewable Hydrocarbon Fuels Produced Therefrom | RENEWABLE ENERGY GROUP, INC. (US) | 2024-04-18 | — | — | US | disclosed |
| CN-116272256-A | Method and device for collecting tobacco fragrance in redried tobacco tail gas | 云南烟叶复烤有限责任公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-112495141-A | Method and system for collecting tobacco fragrance in flue-cured tobacco leaf tail gas | 云南烟叶复烤有限责任公司 | 2021-03-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12275906-B2 | Hydrodeoxygenation of phenolic lipids and renewable hydrocarbon fuels produced therefrom | ALOX15, ALOX12, ALOX15B | ACE2 2773/4885OPRM1 1141/4885LMNA 2902/4885 |
| US-20250263612-A1 | Hydrodeoxygenation of Phenolic Lipids and Renewable Hydrocarbon Fuels Produced Therefrom | ALOX15, ALOX12, ALOX15B | ACE2 2773/4885OPRM1 1141/4885LMNA 2902/4885 |
| US-20240124791-A1 | Hydrodeoxygenation of Phenolic Lipids and Renewable Hydrocarbon Fuels Produced Therefrom | ALOX15, ALOX12, ALOX15B | ACE2 2773/4885OPRM1 1141/4885LMNA 2902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.